These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 29431732)

  • 21. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling.
    Chen CT; Wu PH; Hu CC; Nien HC; Wang JT; Sheu JC; Chow LP
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation.
    Guarnieri T
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase.
    Vogel CF; Goth SR; Dong B; Pessah IN; Matsumura F
    Biochem Biophys Res Commun; 2008 Oct; 375(3):331-5. PubMed ID: 18694728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-Repopulating Cells Induce PD-1 Expression in CD8
    Liu Y; Liang X; Dong W; Fang Y; Lv J; Zhang T; Fiskesund R; Xie J; Liu J; Yin X; Jin X; Chen D; Tang K; Ma J; Zhang H; Yu J; Yan J; Liang H; Mo S; Cheng F; Zhou Y; Zhang H; Wang J; Li J; Chen Y; Cui B; Hu ZW; Cao X; Xiao-Feng Qin F; Huang B
    Cancer Cell; 2018 Mar; 33(3):480-494.e7. PubMed ID: 29533786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.
    Jiang GM; He YW; Fang R; Zhang G; Zeng J; Yi YM; Zhang S; Bu XZ; Cai SH; Du J
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1840-6. PubMed ID: 20691806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
    Bhutia YD; Babu E; Ganapathy V
    Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stem cell transplantation uncovers TDO-AHR regulation of lung dendritic cells in herpesvirus-induced pathology.
    Gurczynski SJ; Pereira NL; Hrycaj SM; Wilke C; Zemans RL; Moore BB
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33491663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
    Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
    Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
    Bekki K; Vogel H; Li W; Ito T; Sweeney C; Haarmann-Stemmann T; Matsumura F; Vogel CF
    Pestic Biochem Physiol; 2015 May; 120():5-13. PubMed ID: 25987214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerogenic Phenotype of IFN-γ-Induced IDO+ Dendritic Cells Is Maintained via an Autocrine IDO-Kynurenine/AhR-IDO Loop.
    Li Q; Harden JL; Anderson CD; Egilmez NK
    J Immunol; 2016 Aug; 197(3):962-70. PubMed ID: 27316681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase mediates the therapeutic effects of adipose-derived stromal/stem cells in experimental periodontitis by modulating macrophages through the kynurenine-AhR-NRF2 pathway.
    Li H; Yuan Y; Chen H; Dai H; Li J
    Mol Metab; 2022 Dec; 66():101617. PubMed ID: 36270612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2 regulates tumor-reactive CD8
    Liu Y; Zhou N; Zhou L; Wang J; Zhou Y; Zhang T; Fang Y; Deng J; Gao Y; Liang X; Lv J; Wang Z; Xie J; Xue Y; Zhang H; Ma J; Tang K; Fang Y; Cheng F; Zhang C; Dong B; Zhao Y; Yuan P; Gao Q; Zhang H; Xiao-Feng Qin F; Huang B
    Nat Immunol; 2021 Mar; 22(3):358-369. PubMed ID: 33432230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salinomycin promotes T-cell proliferation by inhibiting the expression and enzymatic activity of immunosuppressive indoleamine-2,3-dioxygenase in human breast cancer cells.
    Ebokaiwe AP; Njoya EM; Sheng Y; Zhang Z; Li S; Zhou Z; Qiang Z; Peng T; Hussein AA; Zhang G; Lu X; Li L; Wang F
    Toxicol Appl Pharmacol; 2020 Oct; 404():115203. PubMed ID: 32822738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers
    Yang C; Ng CT; Li D; Zhang L
    Front Immunol; 2021; 12():725204. PubMed ID: 34539663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy.
    Ogura J; Miyauchi S; Shimono K; Yang S; Gonchigar S; Ganapathy V; Bhutia YD
    Biochem J; 2017 Sep; 474(20):3391-3402. PubMed ID: 28963435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
    Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
    J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults.
    Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB
    Front Immunol; 2022; 13():917966. PubMed ID: 36248784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
    Cheong JE; Sun L
    Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.